help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BISGAARD, H.
Right arrow Articles by ØJ, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BISGAARD, H.
Right arrow Articles by ØJ, J. A.

Am. J. Respir. Crit. Care Med., Volume 160, Number 4, October 1999, 1227-1231

NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist Montelukast

HANS BISGAARD, LOTTE LOLAND, and JACOB ANH ØJ

Department of Paediatrics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Nitric oxide in exhaled air (FENO) is increased in asthmatic children, probably reflecting aspects of airway inflammation. We have studied the effect of the leukotriene receptor antagonist (LTRA) montelukast on FENO with a view to elucidate potential anti-inflammatory properties of LTRAs. Twenty-six asthmatic children 6 to 15 yr of age completed a double-blind crossover trial of 2 wk of treatment with 5 mg montelukast once daily versus placebo. FENO was measured during single-breath exhalation at a constant flow rate of 0.1 to 0.13 L/s against a resistance of 10 kPa/L/s. Eleven children were receiving maintenance treatment with inhaled steroids during the study (mean daily dose, 273 µg), whereas the other 15 used only inhaled beta 2-agonists as required. The within-subject coefficient of variation of FENO over a 2-wk interval for the 26 children was 38%. FENO was significantly reduced by 20% after the 2-wk treatment with montelukast as compared with placebo as well as compared with baseline. This effect occurred rapidly with a 15% fall in FENO within 2 d. The effect of montelukast on FENO was independent of concurrent steroid treatment. The effect on FENO is probably not caused by bronchodilatation since FENO increased significantly after inhalation of terbutaline. In conclusion, FENO in asthmatic children was significantly decreased from montelukast, which corroborates anti- inflammatory properties of LTRA.




This article has been cited by other articles:


Home page
 Chronic Respiratory DiseaseHome page
G. Rodway, J Choi, L. Hoffman, and J. Sethi
Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications
Chronic Respiratory Disease, February 1, 2009; 6(1): 19 - 29.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
X. Hong, H. Zhou, H-J. Tsai, X. Wang, X. Liu, B. Wang, X. Xu, and X. Xu
Cysteinyl leukotriene receptor 1 gene variation and risk of asthma
Eur. Respir. J., January 1, 2009; 33(1): 42 - 48.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F Gaber, K Daham, A Higashi, N Higashi, A Gulich, I Delin, A James, M Skedinger, P Gyllfors, M Nord, et al.
Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma
Thorax, December 1, 2008; 63(12): 1076 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. G. Lim and C. Mottram
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest, May 1, 2008; 133(5): 1232 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. Montuschi, C. Mondino, P. Koch, G. Ciabattoni, P. J. Barnes, and G. Baviera
Effects of Montelukast Treatment and Withdrawal on Fractional Exhaled Nitric Oxide and Lung Function in Children With Asthma
Chest, December 1, 2007; 132(6): 1876 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. Hakim, D. Vilozni, A. Adler, G. Livnat, A. Tal, and L. Bentur
The Effect of Montelukast on Bronchial Hyperreactivity in Preschool Children
Chest, January 1, 2007; 131(1): 180 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate.
Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145.
[Full Text] [PDF]

Home page
 ChestHome page
F. Buchvald, M. N. Hermansen, K. G. Nielsen, and H. Bisgaard
Exhaled Nitric Oxide Predicts Exercise-Induced Bronchoconstriction in Asthmatic School Children
Chest, October 1, 2005; 128(4): 1964 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Baydur
Not All That Comes Out Is Hot Air
Chest, May 1, 2005; 127(5): 1482 - 1485.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930.
[Full Text] [PDF]

Home page
 ChestHome page
W. Busse and M. Kraft
Cysteinyl Leukotrienes in Allergic Inflammation: Strategic Target for Therapy
Chest, April 1, 2005; 127(4): 1312 - 1326.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. A. Straub, A. Moeller, S. Minocchieri, J. Hamacher, F. H. Sennhauser, G. L. Hall, and J. H. Wildhaber
The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma
Eur. Respir. J., February 1, 2005; 25(2): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. A. Straub, S. Minocchieri, A. Moeller, J. Hamacher, and J. H. Wildhaber
The Effect of Montelukast on Exhaled Nitric Oxide and Lung Function in Asthmatic Children 2 to 5 Years Old
Chest, February 1, 2005; 127(2): 509 - 514.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. A. Kharitonov and P. J. Barnes
Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Sandrini, I. M. Ferreira, C. Gutierrez, J. R. Jardim, N. Zamel, and K. R. Chapman
Effect of Montelukast on Exhaled Nitric Oxide and Nonvolatile Markers of Inflammation in Mild Asthma
Chest, October 1, 2003; 124(4): 1334 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, K. S. van's Gravesande, R. Buscher, J. M. Drazen, and F. Ratjen
Effects of Sex and of Gene Variants in Constitutive Nitric Oxide Synthases on Exhaled Nitric Oxide
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1113 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D B Price, D Hernandez, P Magyar, J Fiterman, K M Beeh, I G James, S Konstantopoulos, R Rojas, J A van Noord, M Pons, et al.
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
Thorax, March 1, 2003; 58(3): 211 - 216.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. O'Sullivan, M. Akveld, C. M. Burke, and L. W. Poulter
Effect of the Addition of Montelukast to Inhaled Fluticasone Propionate on Airway Inflammation
Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 745 - 750.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
F L M Ricciardolo
Multiple roles of nitric oxide in the airways
Thorax, February 1, 2003; 58(2): 175 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Kanniess, K. Richter, S. Janicki, M.B. Schleiss, R.A. Jorres, and H. Magnussen
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Eur. Respir. J., November 1, 2002; 20(5): 1080 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Kanniess, K. Richter, S. Bohme, R.A. Jorres, and H. Magnussen
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Eur. Respir. J., October 1, 2002; 20(4): 853 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
L. Ghiro, S. Zanconato, O. Rampon, V. Piovan, M.F. Pasquale, and E. Baraldi
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Eur. Respir. J., September 1, 2002; 20(3): 630 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
Members of the Task Force:, E. Baraldi, J.C. de Jongste, B. Gaston, K. Alving, P.J. Barnes, H. Bisgaard, A. Bush, C. Gaultier, H. Grasemann, et al.
Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force
Eur. Respir. J., July 1, 2002; 20(1): 223 - 237.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Deykin, A. F. Massaro, J. M. Drazen, and E. Israel
Exhaled Nitric Oxide as a Diagnostic Test for Asthma: Online versus Offline Techniques and Effect of Flow Rate
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1597 - 1601.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
T J Warke, P S Fitch, V Brown, R Taylor, J D M Lyons, M Ennis, and M D Shields
Exhaled nitric oxide correlates with airway eosinophils in childhood asthma
Thorax, May 1, 2002; 57(5): 383 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. KHARITONOV and P. J. BARNES
Exhaled Markers of Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
F. BUCHVALD and H. BISGAARD
FeNO Measured at Fixed Exhalation Flow Rate during Controlled Tidal Breathing in Children from the Age of 2 Yr
Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 699 - 704.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. Bisgaard
Leukotriene Modifiers in Pediatric Asthma Management
Pediatrics, February 1, 2001; 107(2): 381 - 390.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. DEYKIN, O. BELOSTOTSKY, C. HONG, A. F. MASSARO, C. M. LILLY, and E. ISRAEL
Exhaled Nitric Oxide following Leukotriene E4 and Methacholine Inhalation in Patients with Asthma
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1685 - 1689.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. BARALDI, M. SCOLLO, C. ZARAMELLA, S. ZANCONATO, and F. ZACCHELLO
A Simple Flow-Driven Method for Online Measurement of Exhaled NO Starting at the Age of 4 to 5 Years
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1828 - 1832.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. Ménard and E. Y. Bissonnette
Priming of Alveolar Macrophages by Leukotriene D4 . Potentiation of Inflammation
Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 572 - 577.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. M. WILSON, L. C. ORR, E. J. SIMS, O. J. DEMPSEY, and B. J. LIPWORTH
Antiasthmatic Effects of Mediator Blockade versus Topical Corticosteroids in Allergic Rhinitis and Asthma
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1297 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. BISGAARD and K. G. NIELSEN
Bronchoprotection with a Leukotriene Receptor Antagonist in Asthmatic Preschool Children
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 187 - 190.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  Red In Translatin